Accounting for <i>EGFR</i> Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data
Sabine Schmid(University of Bern), Ping Yang(Milken Institute), Beata Świątkowska(Nofer Institute of Occupational Medicine), Jolanta Lissowska, Paul Brennan(Centre international de recherche sur le cancer), Hongbing Shen(Jiangsu Cancer Hospital), Давид Заридзе(Russian Cancer Research Center NN Blokhin), Adonina Tardón(Universidad de Oviedo), Hongxia Ma(Wuhan Prevention and Treatment Center for Occupational Diseases), Sanjay Shete(The University of Texas MD Anderson Cancer Center), Miguel García-Pardo(Hospital Universitario Ramón y Cajal), Angela Cox, Angeline S. Andrew(Dartmouth College), Dana Mateș(National Institute of Public Health), Zhichao Wang(Nanjing University of Chinese Medicine), Nancy Diao(Harvard University), Guillermo Fernández‐Tardón(Universidad de Oviedo), Neil E. Caporaso(Unknown), Alberto Ruano‐Raviña(Universidade de Santiago de Compostela), Takashi Kohno(Gunma University), Bríd M. Ryan(National Institutes of Health), Juntao Xie(Fudan University Shanghai Cancer Center), Ivana Holcátová(Charles University), John K. Field(University of Liverpool), M. Catherine Brown(University Health Network), Lori C. Sakoda(Kaiser Permanente), Lihong Qi(University of California, Davis), Curtis C. Harris(National Cancer Institute), Milan Savić(Centar za Promociju Nauke), Ben Schoettker(German Cancer Research Center), Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Sera Thomas(Lunenfeld-Tanenbaum Research Institute), Michael P.A. Davies(University of Liverpool), Matthew B. Schabath(Moffitt Cancer Center), Aline Fusco Fares(Hospital de Base), Eric J. Duell(Dartmouth College), Letícia Ferro Leal(Universidade de Ribeirão Preto), Hermann Brenner(Universidad de Granada), Mónica Pérez‐Ríos(Universidade de Santiago de Compostela), Maria Teresa Landi(National Institutes of Health), Angela S. Wenzlaff(The Barbara Ann Karmanos Cancer Institute), Mei Jiang(First Affiliated Hospital of Guangzhou Medical University), Ying Wang(University of Tennessee Health Science Center), Mei Dong(Cornell University), Chu Chen(Yunnan University of Finance And Economics), Matthew J Barnett(Fred Hutch Cancer Center), Joelle Soriano(University of Ottawa), Gary E. Goodman(Fred Hutch Cancer Center), Fiona Taylor(Sheffield Teaching Hospitals NHS Foundation Trust), Ann G. Schwartz(The Barbara Ann Karmanos Cancer Institute)
Cited by 2
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k